The risk of pancreaticointestinal anastomosis can be predicted preoperatively

Pancreas

Volumn 13, Issue 2, 1996, Pages 202-208

  Friess, Helmut ^a   Malfertheiner, Peter ^b   Isenmann, Rainer ^a   Kühne, Holger ^a   Beger, Hans G ^c   Büchler, Markus W ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b OTTO VON GUERICKE UNIVERSITY   (Germany)

^c UNIVERSITY OF ULM   (Germany)

Author keywords

Pancreaticointestinal anastomosis; Pancreolauryl test; Postoperative complications; Preoperative prediction

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC PANCREATITIS; CLINICAL ARTICLE; CONTROLLED STUDY; CYSTIC FIBROSIS; FEMALE; HUMAN; HUMAN TISSUE; INTESTINE ANASTOMOSIS; MALE; PANCREAS FUNCTION TEST; PANCREAS RESECTION; PANCREAS TUMOR; PANCREATICODUODENECTOMY; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SURGICAL RISK;

ADULT; AGED; BILE DUCT NEOPLASMS; CHRONIC DISEASE; FEMALE; FIBROSIS; FLUORESCEINS; HUMANS; INDICATORS AND REAGENTS; INTESTINAL FISTULA; MALE; MIDDLE AGED; PANCREAS; PANCREATIC FISTULA; PANCREATIC NEOPLASMS; PANCREATITIS; POSTOPERATIVE COMPLICATIONS; RISK FACTORS;

EID: 0029791347     PISSN: 08853177     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Büchler MW, Friess H, Klempa I, et al. Role of octreotide in the prevention of postoperative complications following pancreatic resection. Am J Surg 1992;163:125-31.
2. Bartoli FG, Arnone GB, Ravera G, Bachi V. Pancreatic fistula and relative mortality in malignant disease after pancreaticoduodenectomy. Review and statistical meta-analysis regarding 5 years of literature. Anticancer Res 1991;11:1831-48.
3. Moossa AR, Gadd M, Lavelle-Jones M. Surgical treatment of exocrine pancreatic cancer. In: Go VLW, Gardner JD, Brooks FP, Lebenthal E, DiMagno EP, Scheele GA, eds. The exocrine pancreas. Biology, pathobiology and diseases. New York: Raven Press, 1986:713-25.
4. Crist DW, Sitzmann JV, Cameron JL. Improved hospital morbidity, mortality and survival after the Whipple procedure. Ann Surg 1987;206:358-65.
5. Howard JM, Kierstead BS. The management of complications of pancreatic resection. In: Beger HG, Büchler M, Malfertheiner P, eds. Standards in pancreatic surgery. Berlin/Heidelberg/New York: Springer, 1993:723-33.
6. Jordan GL Jr. Pancreatic resection for pancreatic cancer. In: Howard JM, Jordan GL Jr, Reber HA, eds. Surgical diseases of the pancreas. Philadelphia: Lea and Febiger, 1987: 666-714.
7. Bakkevold KE, Kambestad B. Morbidity and mortality after radical and palliative pancreatic cancer surgery. Ann Surg 1993;217:356-68.
8. Hayes DH, Bolton JS, Willis GE, Bowen JC. Carcinoma of the ampulla of Vater. Ann Surg 1987;206:572-7.
9. Malfertheiner P, Büchler M, Müller A, Ditschuneit H. Fluorescein dilaureate serum test: A rapid tubeless pancreatic function test. Pancreas 1987;2:53-60.
10. Lankisch PG. Value of indirect pancreatic function tests. In: Beger HG. Büchler M, Ditschuneit H, Malfertheiner P, eds. Chronic pancreatitis. Berlin/Heidelberg/New York: Springer, 1990:291-302.
11. Dominguez-Munoz JE, Pieramico O, Büchler M, Malfertheiner P. Clinical utility of the serum pancreolauryl test in diagnosis and staging of chronic pancreatitis. Am J Gastroenterol 1993;88:1237-41.
12. Friess H, Büchler MW. Pankreaskopfresektion mit Erhaltung des Duodenums. In: Kozuschek W, Paquet KJ, eds. Pankreas, Diagnostik, Therapie. Basel: Karger, 1992:237-45.
13. Büchler MW, Friess H, Bittner R, Beger HG. Duodenum-preserving resection of the head of the pancreas: The Ulm experience. In: Beger HG, Büchler M, Malfertheiner P, eds. Standards in pancreatic surgery. Heidelberg: Springer, 1993:436-49.
14. Traverso LW, Longmire WP. Preservation of the pylorus in pancreaticoduodenectomy. Surg Gynecol Obstet 1978;146: 959-62.
15. Friess H, Yamanaka Y, Büchler MW, et al. Enhanced expression of transforming growth factor-beta isoforms in pancreatic cancer correlates with decreased survival. Gastroenterology 1993;105:1846-56.
16. Friess H, Yamanaka Y, Büchler MW, et al. Increased expression of acidic and basic fibroblast growth factors in chronic pancreatitis. Am J Pathol 1994;144:117-28.
17. Bockman DE, Merlino G. Cytological changes in the pancreas of transgenic mice overexpressing transforming growth factor alpha. Gastroenterology 1992;103:1883-92.
18. Siegel S. Nonparametric statistics for behavioral sciences. New York: McGraw-Hill, 1956.
19. Kausch W. Das Carcinom der Papilla duodeni und seine radikale Entfernung. Beitr Klin Chir 1992;78:439-86.
20. Büchler M, Friess H. Inhibition of pancreatic secretion to prevent postoperative complications following pancreatic resection. Acta Gastroenterol Beig 1993;56:271-8.
21. Buchler M, Friess H. Prevention of postoperative complications following pancreatic surgery. Digestion 1993;54(Suppl 1):41-6.
22. Pederzoli P, Bassi C, Falconi M, Camboni MG. Efficacy of octreotide in the prevention of complications of elective pancreatic surgery. Italian Study Group. Br J Surg 1994;81-265-9.
23. Montorsi M, Zago M, Mosca F, et al. Efficacy of octreotide in the prevention of pancreatic fistula after elective pancreatic resections: a prospective, controlled, randomized clinical trial. Surgery 1995;117:26-31.
24. Friess H, Beger HG, Sulkowski U, et al. Randomized controlled multicentre study of the prevention of complications by octreotide in patients undergoing surgery for chronic pancreatitis. Br J Surg 1995;82:1270-3.